Integer (ITGR) Expected to Announce Quarterly Earnings on Thursday

Integer (NYSE:ITGR - Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Thursday, February 20th. Analysts expect the company to announce earnings of $1.46 per share and revenue of $446.28 million for the quarter. Parties interested in participating in the company's conference call can do so using this link.

Integer Price Performance

NYSE:ITGR traded up $2.27 during trading hours on Friday, reaching $140.94. 201,506 shares of the company were exchanged, compared to its average volume of 220,089. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The stock's 50-day moving average is $137.84 and its 200-day moving average is $131.82. The firm has a market cap of $4.73 billion, a PE ratio of 43.50, a price-to-earnings-growth ratio of 1.79 and a beta of 1.13. Integer has a twelve month low of $94.56 and a twelve month high of $146.36.

Analyst Ratings Changes

ITGR has been the subject of a number of research analyst reports. Citigroup upped their price objective on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research report on Wednesday, December 11th. Wells Fargo & Company restated an "overweight" rating and set a $160.00 price objective on shares of Integer in a research report on Tuesday, December 3rd. KeyCorp increased their target price on shares of Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Benchmark raised their price target on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Monday, October 21st. Finally, Piper Sandler reissued an "overweight" rating and issued a $140.00 price target (up from $125.00) on shares of Integer in a research note on Friday, October 25th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Integer presently has an average rating of "Moderate Buy" and an average target price of $146.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.